China's Yongsheng Intelligence and Shanghai AI Lab Release AI for Bio Systems
Yongsheng Intelligence, a subsidiary of MGI Tech, and the Shanghai Artificial Intelligence Laborator...
NVIDIA Launches BioNeMo Agent Toolkit, Adopted by Over 50 Companies
NVIDIA has released the NVIDIA BioNeMo Agent Toolkit, a domain-specific toolkit focused on life scie...
Karnataka Explores Biotech Financing Framework and AI Innovation
Karnataka is exploring the establishment of a dedicated support framework for biotechnology enterpri...
Israel's Evogene Partners with Google Cloud to Upgrade ChemPass AI
Evogene Ltd. recently announced the completion of a significant milestone in collaboration with Goog...
Stanford University discovers that inhibiting the 15-PGDH enzyme can repair articular cartilage
Researchers at Stanford University have promoted the repair of articular cartilage in animal experim...
Brazil's Funed invests R$10 million to convert abandoned building into biotechnology center, to start operations by year-end
The government of Minas Gerais has decided to convert an abandoned building in the Gameleira neighbo...
University of Michigan Creates Database of 50,000 Chemical Experiments to Accelerate Drug Discovery
The team of Tim Cernak at the University of Michigan College of Pharmacy has created an open-access ...
NVIDIA Launches BioNeMo Agent Toolkit to Accelerate Scientific Discovery
NVIDIA has launched the BioNeMo Agent Toolkit, providing AI agents in the life sciences field with o...
AbbVie to Acquire Apogee for $10.9 Billion to Strengthen Immunology Drug Pipeline
On June 22, local time, U.S. pharmaceutical company AbbVie announced it would acquire biotechnology ...
Ascentage Pharma and K2 Reach Approximately $960 Million License Agreement for ATG-106
Ascentage Pharma Group and K2 Therapeutics have entered into an exclusive license agreement for a pr...
Spanish Team Discovers OLE Molecule Can Restore Microglial Function and Improve Cognition in Alzheimer's Disease
A research team from the Institute of Neuroscience at the Spanish National Research Council - Miguel...
China Approves World's First Solid Tumor CAR-T: CARsgen's Satri-cel for Market
The National Medical Products Administration (NMPA) has approved, through a priority review and appr...
AbbVie Acquires Apogee Therapeutics for $10.9 Billion
AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, a deal aimed at strengthening th...
China's Ministry of Commerce Supports Foreign Investment in High-Quality Development of the Pharmaceutical Industry
Recently, China's Ministry of Commerce, together with the National Development and Reform Commission...
Sylvester Cancer Center in the U.S. Discovers New Pancreatic Cancer Target and Initiates Clinical Trial
Pancreatic cancer treatment has a new potential target. Researchers at the Sylvester Comprehensive C...
ChemT Biotechnology Secures $5 Million in Funding to Advance AI-Driven Biomanufacturing Platform
ChemT Biotechnology has announced the completion of a total of $5 million in funding, consisting of ...
Japan Approves Avastin as World's First Treatment for Neurofibromatosis Type 2
The Japanese Ministry of Health, Labour and Welfare has approved bevacizumab (Avastin) as an additio...
US-based Boltz Partners with Takeda to Deploy Biomolecular AI Models
Boltz PBC, a US-based applied AI research lab, announced on June 18, 2026, a collaboration with Take...
CureGene Pharmaceutical's Antiplatelet Drug Evategrel Completes First Patient Dosing in U.S. Pivotal Trial
CureGene Pharmaceutical announced that its self-developed antiplatelet drug Evategrel (CG-0255) has ...
US Traws Pharma Advances Clinical Development of Long-Acting Anti-Influenza Drug TXM
Traws Pharma (Nasdaq: TRAW) is advancing the clinical development of its influenza candidate Tivoxav...
Memento Completes $93 Million Series A Financing, Obtains Global License for Bispecific Antibody
Memento Medicines Completes $93 Million Series A Financing and Obtains Global License for MMT-205 Bi...
Merck & Co. and Protillion Announce AI Drug Discovery Collaboration with $510 Million in Milestone Payments
Merck & Co. has entered into a multi-target discovery collaboration and licensing agreement with...
Chinese AI Protein Design Platform MoleculeMind Completes Over $100 Million in Financing
MoleculeMind, a Chinese AI protein design platform company, has completed its Series A financing rou...
China's ByteDance Spins Off AI Drug Discovery Unit, Seeks Independent Funding
ByteDance's artificial intelligence drug discovery unit has initiated a spin-off and is seeking inde...
Bayer Becomes Founding Member of International Society for Stem Cell Research Consortium
The International Society for Stem Cell Research (ISSCR) announced that Bayer has become a founding ...
QIAGEN Expands QIAcuity Digital PCR Ecosystem with Over 3,200 Installed Units
QIAGEN N.V. announced the expansion of its QIAcuity digital PCR (dPCR) ecosystem, supporting broader...
Icelandic Biotech Company Alvotech Announces $152 Million Financing
Alvotech (NASDAQ: ALVO; ALVO-SDB) announced the pricing of its underwritten public offering of 22,66...
EU Proposes Biotech Act to Balance Patent Protection and Generic Competition
The European Union plans to introduce the Biotech Act to enhance the global competitiveness of Europ...
Cleveland Clinic and IBM Co-Host Forum Showcasing Advances in Quantum Computing and AI in Healthcare
The third annual Cleveland Discovery and Innovation Forum, co-hosted by Cleveland Clinic and IBM, wa...
U.S. FDA Approves KEYTRUDA in Combination with WELIREG for Adjuvant Treatment of Renal Cell Carcinoma
The U.S. FDA has approved KEYTRUDA (pembrolizumab) and KEYTRUDA QLEX (pembrolizumab with berahyaluro...